bioRxivMicrobiology
Global protein responses of multi-drug resistant plasmid containing Escherichia coli to ampicillin, cefotaxime, imipenem and ciprofloxacin.
Abstract
Antimicrobial resistance (AMR) and multi-drug resistance (MDR) in pathogenic bacteria are frequently mediated by plasmids. However, plasmids do not exist in isolation but rather require the bacterial host interaction in order to produce the AMR phenotype. This study aimed to utilise mass spectrometry-based proteomics to reveal the plasmid and chromosomally derived protein profile of Escherichia coli under antimicrobial stress. This was achieved by comparing the proteomes of E. coli containing the MDR pEK499 plasmid, under ampicillin, cefotaxime, imipenem or ciprofloxacin stress with the proteomes of these bacteria grown in the absence of antimicrobial. Our analysis identified statistically significant differentially abundant proteins common to groups exposed to the {beta}-lactam antimicrobials but not ciprofloxacin, indicating a {beta}-lactam stress response to exposure from this class of drugs, irrespective of {beta}-lactam resistance or susceptibility. These include ecotin and free methionine-R-sulfoxide reductase. These data also identified distinct differences in the cellular response to each {beta}-lactam. Data arising from comparisons of the proteomes of ciprofloxacin-treated E. coli and controls detected an increase in the relative abundance of proteins associated with ribosomes, translation, the TCA-cycle and several proteins associated with detoxification and a decrease in the relative abundances of proteins associated with stress response, including oxidative stress. We identified changes in proteins associated with persister formation in the presence of ciprofloxacin but not the {beta}-lactams. The plasmid proteome differed across each treatment and did not follow the pattern of antimicrobial - AMR protein associations. For example, a relative increase in the amount of blaCTX-M-15 in the presence of cefotaxime and ciprofloxacin but not the other {beta}-lactams, suggesting regulation of the blaCTX-M-15 protein production. The proteomic data from the this study provided novel insights into the proteins produced from the chromosome and plasmid under different antimicrobial stresses. These data also identified novel proteins not previously associated with AMR or antimicrobials responses in pathogens, which may well represent potential targets of AMR inhibition.
- organism: E. coli
- assay: proteomics
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multidrug resistance plasmids commonly reprogramme expression of metabolic genes in Escherichia coli
R. J. Hall, A. E. Snaith, … A. McNally·bioRxiv·Nov 6, 2023
- Comprehensive proteomic and metabolomic profiling of mcr-1 mediated colistin resistance in Escherichia coli
- Integrated Resistome and Quantitative Proteomics Reveal Coordinated Resistance Architecture in MDR and XDR Gram-Negative ICU Pathogens
Aldo Â. M. Lima, Dilza Silva, … Érico Arruda·bioRxiv·Apr 20, 2026
- Colistin resistance in Escherichia coli confers protection of the cytoplasmic but not outer membrane from the polymyxin antibiotic
M. Humphrey, G. Larrouy-Maumus, … A. M. Edwards·bioRxiv·Jul 21, 2021
- β-lactamase expression induces collateral sensitivity in Escherichia coli
C. Herencias, L. Alvaro-Llorente, … J. Rodriguez-Beltran·bioRxiv·Nov 22, 2023
- Longitudinal dynamics of gut plasmidome and antibiotic resistance during antibiotic therapy: a case report
Ilmur Jonsdottir, Sean Meaden, … Reetta K. Penttinen·bioRxiv·Apr 12, 2025